Medicines Co (MDCO) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medicines Co  (NASDAQ: MDCO)


Medicines Co's ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medicines Co's ROI in the third quarter of 2019?
Medicines Co recorded a cumulative net loss of $-236 million during 12 months ending in the third quarter of 2019, resulting in a negative return on investment (ROI) of -32.36%.

Within the Healthcare sector 385 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 0 to 3776.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM 3.79 % 2.19 % -1.31 % -11.42 % -30.31 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 474 892 773 783 656
Return On Investment (TTM) -32.36 % -28.09 % -29.03 % -16.98 % -36.79 %
MDCO's Overall Ranking # 3776 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -5.86 % 6.19 % 0.76 % 3.05 % -7.31 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -236 -218 -212 -123 -259

MDCO Company Profile >> Back to MDCO Roi Comparisons >> See Annual MDCO Return On Investment



Return On Investment MDCO's Ranking
Within: No.
Industry # 151
Sector # 386
Overall # 3776

Return On Investment Statistics
High Average Low
3.29 %
-23.32 %
-86.51 %
(Sep 30 2013)   (Dec 31 2017)







Financial Statements
Medicines Co's III. Quarter Investments $ 474 Millions MDCO's Balance sheet
Medicines Co's III. Quarter Income $ -74 Millions Quarterly MDCO's Income Statement
MDCO's Income by Division See MDCO's Income by Division


MDCO Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 783 697 1,461 1,270 1,481
Y / Y Investment Growth 12.3 % -52.25 % 14.98 % -14.25 % -5.44 %
Net Income in Millions -123 -708 -119 -353 -32
Y / Y Net Income Growth - - - - -
Annual Return On Investment -15.72 % -101.56 % -8.16 % -27.77 % -2.17 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDCO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDCO's Competitors
Subscribers only: Roi for Medicines Co's Suppliers
Subscribers only: Return On Investment for MDCO's Customers

Other Ratios
MDCO's Roa MDCO's Inventory Turnover Ratio MDCO's Growth Rates MDCO's Dividend Statistics
MDCO's Profitability Ratios MDCO's Asset Turnover Ratio MDCO's Dividend Growth
MDCO's Roe MDCO's Valuation Ratios MDCO's Financial Strength Ratios MDCO's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.